Morgan Stanley (MS) Shares Bought by Bremer Trust National Association

Bremer Trust National Association increased its holdings in Morgan Stanley (NYSE:MS) by 31.0% in the 4th quarter, according to its most recent filing with the SEC. The institutional investor owned 20,245 shares of the financial services provider’s stock after buying an additional 4,795 shares during the quarter. Bremer Trust National Association’s holdings in Morgan Stanley were worth $1,062,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also added to or reduced their stakes in MS. Financial Counselors Inc. increased its holdings in Morgan Stanley by 6.7% in the 2nd quarter. Financial Counselors Inc. now owns 6,332 shares of the financial services provider’s stock worth $282,000 after buying an additional 400 shares in the last quarter. Stephens Inc. AR grew its stake in shares of Morgan Stanley by 18.9% during the 2nd quarter. Stephens Inc. AR now owns 14,174 shares of the financial services provider’s stock valued at $632,000 after purchasing an additional 2,249 shares during the period. Raymond James Trust N.A. grew its stake in shares of Morgan Stanley by 3.5% during the 2nd quarter. Raymond James Trust N.A. now owns 15,327 shares of the financial services provider’s stock valued at $682,000 after purchasing an additional 524 shares during the period. Icon Advisers Inc. Co. grew its stake in shares of Morgan Stanley by 38.8% during the 2nd quarter. Icon Advisers Inc. Co. now owns 61,900 shares of the financial services provider’s stock valued at $2,758,000 after purchasing an additional 17,300 shares during the period. Finally, Comerica Securities Inc. bought a new stake in shares of Morgan Stanley during the 2nd quarter valued at about $213,000. Institutional investors own 85.49% of the company’s stock.

Morgan Stanley (NYSE MS) opened at $55.12 on Friday. Morgan Stanley has a 12-month low of $40.06 and a 12-month high of $55.14. The company has a debt-to-equity ratio of 2.68, a quick ratio of 0.74 and a current ratio of 0.74. The firm has a market capitalization of $97,988.13, a PE ratio of 15.27, a PEG ratio of 0.90 and a beta of 1.65.

Morgan Stanley (NYSE:MS) last posted its quarterly earnings data on Tuesday, October 17th. The financial services provider reported $0.93 earnings per share for the quarter, beating the Zacks’ consensus estimate of $0.81 by $0.12. Morgan Stanley had a return on equity of 10.07% and a net margin of 16.76%. The firm had revenue of $9.20 billion for the quarter, compared to analysts’ expectations of $9.05 billion. During the same period in the previous year, the firm earned $0.80 EPS. The business’s quarterly revenue was up 3.2% on a year-over-year basis. sell-side analysts predict that Morgan Stanley will post 3.58 earnings per share for the current year.

In related news, insider Keishi Hotsuki sold 25,000 shares of the business’s stock in a transaction that occurred on Tuesday, November 28th. The stock was sold at an average price of $50.00, for a total value of $1,250,000.00. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, President Thomas Colm Kelleher sold 40,000 shares of the business’s stock in a transaction that occurred on Monday, October 23rd. The stock was sold at an average price of $50.59, for a total value of $2,023,600.00. Following the completion of the transaction, the president now directly owns 692,037 shares in the company, valued at $35,010,151.83. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 85,247 shares of company stock worth $4,284,364. Insiders own 0.35% of the company’s stock.

MS has been the subject of a number of recent research reports. Wells Fargo & Co set a $55.00 price target on Morgan Stanley and gave the company a “hold” rating in a research note on Wednesday, December 20th. Zacks Investment Research upgraded Morgan Stanley from a “hold” rating to a “buy” rating and set a $59.00 price target for the company in a research note on Wednesday, January 3rd. JPMorgan Chase & Co. set a $53.00 price target on Morgan Stanley and gave the company a “buy” rating in a research note on Friday, September 15th. Barclays boosted their price target on Morgan Stanley from $48.00 to $52.00 and gave the company an “equal weight” rating in a research note on Wednesday, October 18th. Finally, Berenberg Bank restated a “hold” rating and set a $40.00 price target on shares of Morgan Stanley in a research note on Thursday, September 21st. One research analyst has rated the stock with a sell rating, seven have given a hold rating, eighteen have issued a buy rating and one has given a strong buy rating to the company’s stock. The company presently has a consensus rating of “Buy” and a consensus target price of $53.11.

TRADEMARK VIOLATION NOTICE: “Morgan Stanley (MS) Shares Bought by Bremer Trust National Association” was first reported by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are viewing this piece of content on another publication, it was illegally copied and reposted in violation of US & international copyright and trademark law. The legal version of this piece of content can be viewed at https://www.dispatchtribunal.com/2018/01/13/morgan-stanley-ms-shares-bought-by-bremer-trust-national-association.html.

Morgan Stanley Profile

Morgan Stanley is a financial holding company. The Company’s segments include Institutional Securities, Wealth Management and Investment Management. The Company’s Institutional Securities business segment provides investment banking, sales and trading, and other services to corporations, governments, financial institutions and high-to-ultra high net worth clients.

Want to see what other hedge funds are holding MS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Morgan Stanley (NYSE:MS).

Institutional Ownership by Quarter for Morgan Stanley (NYSE:MS)

Receive News & Ratings for Morgan Stanley Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Morgan Stanley and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply